Article | 8 March 2021
Advanced digital and data competencies—combined with human interaction and engagement—are indispensable to creating and scaling the high-quality B2B buying experiences that customers expect.
Slideshow | 5 February 2021
Here are some facts to clear up the confusion.
Article | 12 January 2021
Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.
Article | 15 December 2020
Industry leaders set themselves apart with five key practices.
Article | 22 October 2020
As the current crisis demonstrates, biopharma and medtech companies need to safeguard their networks against unanticipated disruptions. Here’s how.
Article | 14 October 2020
Focusing on the best businesses is not as easy as it sounds. This five-step approach helps companies generate the highest investment returns.
Article | 13 October 2020
By combining technology and human capabilities, a finance function can orchestrate the work of other departments and help the company achieve its strategic objectives.
Article | 28 July 2020
A big gap in our overall testing capability remains unfilled—the ability to tell people quickly and reliably if they have been infected.
Article | 14 July 2020
The medtech industry is poised for strong growth but faces challenges too. For private equity investors, making sense of the market requires understanding the range of investment themes.
Article | 7 July 2020
Medtech and biopharma companies can rebound from the current crisis and prepare for an uncertain future.